Sandbox reserved 919: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
 
Line 26: Line 26:
Hormone-sensitive lipase can be inhibited by phenylmethylsufonyl flouride ([http://en.wikipedia.org/wiki/PMSF PMSF]) covalently bound to the <scene name='58/580297/Pmsf_surface/4'>active site</scene>. The experiments performed to test this inhibition used different lipases obtained from [http://en.wikipedia.org/wiki/Bacillus_coagulans ''Bacillus coagulans''] as well as lipases from different areas of the human body.<ref name="Kanwar">PMID:23923547</ref> PMSF inhibits hydrolase by binding to the catalytic serine residue of the [http://proteopedia.org/wiki/index.php/Serine_Proteases serine protease] active site which disrupts the nucleophilic activity of the catalytic serine. The sulfur of PMSF binds to the oxygen of the hydroxyl group on the serine residue to form this covalent bond. This inhibitor will only bind to the active site of the catalytic serine because of its participation in the charge relay of the catalytic triad. This hyper activity, indicated by increased temperature (shown in red) around the active site <scene name='58/580296/Meshligand/3'>here</scene>, allows the sulfonyl group of PMSF to covalently bind to the catalytic serine residue to disrupt its activity.<ref name="Kim">PMID: 19715665 </ref> Because of this catalytic serine residue specificity, PMSF does not inhibit all kinds of lipases, such as [http://en.wikipedia.org/wiki/Pancreatic_lipase pancreatic lipase] and lipolase.<ref name="Kanwar"> PMSF is highly degradable in aqueous solutions as it has a [http://en.wikipedia.org/wiki/Half-life half-life] range of 35-110 minutes at  [http://en.wikipedia.org/wiki/PH pH] levels of 7.0-8.0.<ref name="Gordon">PMID:26289</ref> <scene name='58/580297/Pmsf_binding/2'>PMSF binding</scene> induces only a minor conformational change from the <scene name='58/580297/3dnm_ligandsite_triad_chains/7'>native protein</scene>.<ref name="Kim">  
Hormone-sensitive lipase can be inhibited by phenylmethylsufonyl flouride ([http://en.wikipedia.org/wiki/PMSF PMSF]) covalently bound to the <scene name='58/580297/Pmsf_surface/4'>active site</scene>. The experiments performed to test this inhibition used different lipases obtained from [http://en.wikipedia.org/wiki/Bacillus_coagulans ''Bacillus coagulans''] as well as lipases from different areas of the human body.<ref name="Kanwar">PMID:23923547</ref> PMSF inhibits hydrolase by binding to the catalytic serine residue of the [http://proteopedia.org/wiki/index.php/Serine_Proteases serine protease] active site which disrupts the nucleophilic activity of the catalytic serine. The sulfur of PMSF binds to the oxygen of the hydroxyl group on the serine residue to form this covalent bond. This inhibitor will only bind to the active site of the catalytic serine because of its participation in the charge relay of the catalytic triad. This hyper activity, indicated by increased temperature (shown in red) around the active site <scene name='58/580296/Meshligand/3'>here</scene>, allows the sulfonyl group of PMSF to covalently bind to the catalytic serine residue to disrupt its activity.<ref name="Kim">PMID: 19715665 </ref> Because of this catalytic serine residue specificity, PMSF does not inhibit all kinds of lipases, such as [http://en.wikipedia.org/wiki/Pancreatic_lipase pancreatic lipase] and lipolase.<ref name="Kanwar"> PMSF is highly degradable in aqueous solutions as it has a [http://en.wikipedia.org/wiki/Half-life half-life] range of 35-110 minutes at  [http://en.wikipedia.org/wiki/PH pH] levels of 7.0-8.0.<ref name="Gordon">PMID:26289</ref> <scene name='58/580297/Pmsf_binding/2'>PMSF binding</scene> induces only a minor conformational change from the <scene name='58/580297/3dnm_ligandsite_triad_chains/7'>native protein</scene>.<ref name="Kim">  


As mentioned before, increased activity of HSL can possibly lead to disorders such as atherosclerosis, obesity, and [http://en.wikipedia.org/wiki/Diabetes_mellitus#Type_2 type 2 diabetes]. Increased concentration of free fatty acids ([http://en.wikipedia.org/wiki/Fatty_acid#Free_fatty_acids FFA]) in skeletal muscles has been reported in many cases of obesity and type 2 diabetes. Increased inhibition of HSL through synthetic inhibitors such as PMSF could, in theory, be a possible route for decreasing FFA concentration.<ref name="Kraemer">PMID: 12364542 </ref>
As mentioned before, increased activity of HSL can possibly lead to disorders such as atherosclerosis, obesity, and [http://en.wikipedia.org/wiki/Diabetes_mellitus#Type_2 type 2 diabetes]. High concentration of free fatty acids ([http://en.wikipedia.org/wiki/Fatty_acid#Free_fatty_acids FFA]) in skeletal muscles has been reported in many cases of obesity and type 2 diabetes. Increased inhibition of HSL through synthetic inhibitors such as PMSF could, in theory, be a possible route for decreasing FFA concentration.<ref name="Kraemer">PMID: 12364542 </ref>


As mentioned before, increased activity of HSL can possibly lead to disorders such as atherosclerosis, obesity, and [http://en.wikipedia.org/wiki/Diabetes_mellitus#Type_2 type 2 diabetes]. Increased concentration of free fatty acids ([http://en.wikipedia.org/wiki/Fatty_acid#Free_fatty_acids FFA]) in skeletal muscles has been reported in many cases of obesity and type 2 diabetes. Increased inhibition of HSL through synthetic inhibitors such as PMSF could, in theory, be a possible route for decreasing FFA concentration.<ref name="Kraemer">PMID: 12364542 </ref>
As mentioned before, increased activity of HSL can possibly lead to disorders such as atherosclerosis, obesity, and [http://en.wikipedia.org/wiki/Diabetes_mellitus#Type_2 type 2 diabetes]. High concentration of free fatty acids ([http://en.wikipedia.org/wiki/Fatty_acid#Free_fatty_acids FFA]) in skeletal muscles has been reported in many cases of obesity and type 2 diabetes. Increased inhibition of HSL through synthetic inhibitors such as PMSF could, in theory, be a possible route for decreasing FFA concentration.<ref name="Kraemer">PMID: 12364542 </ref>


</StructureSection>
</StructureSection>

Latest revision as of 12:46, 22 April 2014

Hormone-sensitive lipase

Hormone-Sensitive Lipase from 3dnm

Drag the structure with the mouse to rotate


Additional pages about hormone-sensitive lipase

References